Company Filing History:
Years Active: 2016
Title: Rakesh Kumar Bhasin – Innovator in Pharmaceutical Composition
Introduction
Rakesh Kumar Bhasin is a notable inventor located in Maharashtra, India. He has contributed significantly to the field of pharmaceuticals, focusing on enhancing drug bioavailability and solubility. His innovative work has garnered attention in the research community and among pharmaceutical companies.
Latest Patents
Rakesh Kumar Bhasin holds a patent for a novel pharmaceutical composition designed to improve the bioavailability of poorly water-soluble drugs. The patent details an oral pharmaceutical composition that includes active ingredients, specifically the antiparasitic and antipneumocystic drug Atovaquone, either alone or in combination with Proguanil. This groundbreaking invention addresses critical challenges in drug formulation by enhancing aqueous dissolution and absorption, which can lead to better therapeutic outcomes for patients.
Career Highlights
Bhasin is currently associated with Ipca Laboratories Limited, a leading pharmaceutical company that focuses on healthcare and innovative research. His work at the company allows him to apply his knowledge and skills in real-world applications, significantly contributing to the advancement of pharmaceutical solutions.
Collaborations
Throughout his career, Rakesh Kumar Bhasin has collaborated with esteemed colleagues such as Ashok Kumar and Dharmendra Singh. These collaborations highlight the importance of teamwork in the innovation process and the sharing of knowledge among skilled professionals in the industry.
Conclusion
Rakesh Kumar Bhasin stands out as an accomplished inventor in the pharmaceutical sector with his innovative patent that seeks to optimize drug delivery. His work at Ipca Laboratories Limited, coupled with strong collaborations with fellow professionals, positions him as a key figure in developing effective pharmaceutical solutions. The advancements resulting from his research are vital for improving healthcare outcomes and show great promise in addressing the challenges associated with drug solubility and bioavailability.